INHIBITORS OF NLRP3

The present invention relates to novel compounds of Formulae I-XI: wherein each A, A′, Q, Q′, W, Rw, Y, and Z, and -- are as defined herein, which inhibit NOD-like receptor protein 3 (NLRP3) inflammasome activity. The invention further relates to the processes for their preparation, pharmaceutical c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BEJCEK, Lauren, HOSSEYNI, Seyedmorteza, SYDORENKO, Nadiya, PILLAI, Meenu, HUARTE, Eduardo, ZHANG, Nanjing, GONG, Hua, Handoko, LI, Jing, BARRAZA, Scott, J, WOLL, Matthew, G, ALAM, Rauful, PARKER, Erica, N, ZHANG, Xiaoyan, GILBERT, Bradley, B, NIEDERER, Kyle, ZHENG, Tianyi, TURPOFF, Anthony, JEON, Woohyung, LIU, Yao, ZHANG, Yan, RASTELLI, Ettore
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BEJCEK, Lauren
HOSSEYNI, Seyedmorteza
SYDORENKO, Nadiya
PILLAI, Meenu
HUARTE, Eduardo
ZHANG, Nanjing
GONG, Hua
Handoko
LI, Jing
BARRAZA, Scott, J
WOLL, Matthew, G
ALAM, Rauful
PARKER, Erica, N
ZHANG, Xiaoyan
GILBERT, Bradley, B
NIEDERER, Kyle
ZHENG, Tianyi
TURPOFF, Anthony
JEON, Woohyung
LIU, Yao
ZHANG, Yan
RASTELLI, Ettore
description The present invention relates to novel compounds of Formulae I-XI: wherein each A, A′, Q, Q′, W, Rw, Y, and Z, and -- are as defined herein, which inhibit NOD-like receptor protein 3 (NLRP3) inflammasome activity. The invention further relates to the processes for their preparation, pharmaceutical compositions and medicaments containing them, and their use in the treatment of diseases and disorders mediated by NLRP3.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4392414A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4392414A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4392414A13</originalsourceid><addsrcrecordid>eNrjZBD29PPwdPIM8Q8KVvB3U_DzCQow5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJsaWRiaGJo6GxkQoAQAagR3X</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INHIBITORS OF NLRP3</title><source>esp@cenet</source><creator>BEJCEK, Lauren ; HOSSEYNI, Seyedmorteza ; SYDORENKO, Nadiya ; PILLAI, Meenu ; HUARTE, Eduardo ; ZHANG, Nanjing ; GONG, Hua ; Handoko ; LI, Jing ; BARRAZA, Scott, J ; WOLL, Matthew, G ; ALAM, Rauful ; PARKER, Erica, N ; ZHANG, Xiaoyan ; GILBERT, Bradley, B ; NIEDERER, Kyle ; ZHENG, Tianyi ; TURPOFF, Anthony ; JEON, Woohyung ; LIU, Yao ; ZHANG, Yan ; RASTELLI, Ettore</creator><creatorcontrib>BEJCEK, Lauren ; HOSSEYNI, Seyedmorteza ; SYDORENKO, Nadiya ; PILLAI, Meenu ; HUARTE, Eduardo ; ZHANG, Nanjing ; GONG, Hua ; Handoko ; LI, Jing ; BARRAZA, Scott, J ; WOLL, Matthew, G ; ALAM, Rauful ; PARKER, Erica, N ; ZHANG, Xiaoyan ; GILBERT, Bradley, B ; NIEDERER, Kyle ; ZHENG, Tianyi ; TURPOFF, Anthony ; JEON, Woohyung ; LIU, Yao ; ZHANG, Yan ; RASTELLI, Ettore</creatorcontrib><description>The present invention relates to novel compounds of Formulae I-XI: wherein each A, A′, Q, Q′, W, Rw, Y, and Z, and -- are as defined herein, which inhibit NOD-like receptor protein 3 (NLRP3) inflammasome activity. The invention further relates to the processes for their preparation, pharmaceutical compositions and medicaments containing them, and their use in the treatment of diseases and disorders mediated by NLRP3.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240703&amp;DB=EPODOC&amp;CC=EP&amp;NR=4392414A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240703&amp;DB=EPODOC&amp;CC=EP&amp;NR=4392414A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BEJCEK, Lauren</creatorcontrib><creatorcontrib>HOSSEYNI, Seyedmorteza</creatorcontrib><creatorcontrib>SYDORENKO, Nadiya</creatorcontrib><creatorcontrib>PILLAI, Meenu</creatorcontrib><creatorcontrib>HUARTE, Eduardo</creatorcontrib><creatorcontrib>ZHANG, Nanjing</creatorcontrib><creatorcontrib>GONG, Hua</creatorcontrib><creatorcontrib>Handoko</creatorcontrib><creatorcontrib>LI, Jing</creatorcontrib><creatorcontrib>BARRAZA, Scott, J</creatorcontrib><creatorcontrib>WOLL, Matthew, G</creatorcontrib><creatorcontrib>ALAM, Rauful</creatorcontrib><creatorcontrib>PARKER, Erica, N</creatorcontrib><creatorcontrib>ZHANG, Xiaoyan</creatorcontrib><creatorcontrib>GILBERT, Bradley, B</creatorcontrib><creatorcontrib>NIEDERER, Kyle</creatorcontrib><creatorcontrib>ZHENG, Tianyi</creatorcontrib><creatorcontrib>TURPOFF, Anthony</creatorcontrib><creatorcontrib>JEON, Woohyung</creatorcontrib><creatorcontrib>LIU, Yao</creatorcontrib><creatorcontrib>ZHANG, Yan</creatorcontrib><creatorcontrib>RASTELLI, Ettore</creatorcontrib><title>INHIBITORS OF NLRP3</title><description>The present invention relates to novel compounds of Formulae I-XI: wherein each A, A′, Q, Q′, W, Rw, Y, and Z, and -- are as defined herein, which inhibit NOD-like receptor protein 3 (NLRP3) inflammasome activity. The invention further relates to the processes for their preparation, pharmaceutical compositions and medicaments containing them, and their use in the treatment of diseases and disorders mediated by NLRP3.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBD29PPwdPIM8Q8KVvB3U_DzCQow5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJsaWRiaGJo6GxkQoAQAagR3X</recordid><startdate>20240703</startdate><enddate>20240703</enddate><creator>BEJCEK, Lauren</creator><creator>HOSSEYNI, Seyedmorteza</creator><creator>SYDORENKO, Nadiya</creator><creator>PILLAI, Meenu</creator><creator>HUARTE, Eduardo</creator><creator>ZHANG, Nanjing</creator><creator>GONG, Hua</creator><creator>Handoko</creator><creator>LI, Jing</creator><creator>BARRAZA, Scott, J</creator><creator>WOLL, Matthew, G</creator><creator>ALAM, Rauful</creator><creator>PARKER, Erica, N</creator><creator>ZHANG, Xiaoyan</creator><creator>GILBERT, Bradley, B</creator><creator>NIEDERER, Kyle</creator><creator>ZHENG, Tianyi</creator><creator>TURPOFF, Anthony</creator><creator>JEON, Woohyung</creator><creator>LIU, Yao</creator><creator>ZHANG, Yan</creator><creator>RASTELLI, Ettore</creator><scope>EVB</scope></search><sort><creationdate>20240703</creationdate><title>INHIBITORS OF NLRP3</title><author>BEJCEK, Lauren ; HOSSEYNI, Seyedmorteza ; SYDORENKO, Nadiya ; PILLAI, Meenu ; HUARTE, Eduardo ; ZHANG, Nanjing ; GONG, Hua ; Handoko ; LI, Jing ; BARRAZA, Scott, J ; WOLL, Matthew, G ; ALAM, Rauful ; PARKER, Erica, N ; ZHANG, Xiaoyan ; GILBERT, Bradley, B ; NIEDERER, Kyle ; ZHENG, Tianyi ; TURPOFF, Anthony ; JEON, Woohyung ; LIU, Yao ; ZHANG, Yan ; RASTELLI, Ettore</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4392414A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BEJCEK, Lauren</creatorcontrib><creatorcontrib>HOSSEYNI, Seyedmorteza</creatorcontrib><creatorcontrib>SYDORENKO, Nadiya</creatorcontrib><creatorcontrib>PILLAI, Meenu</creatorcontrib><creatorcontrib>HUARTE, Eduardo</creatorcontrib><creatorcontrib>ZHANG, Nanjing</creatorcontrib><creatorcontrib>GONG, Hua</creatorcontrib><creatorcontrib>Handoko</creatorcontrib><creatorcontrib>LI, Jing</creatorcontrib><creatorcontrib>BARRAZA, Scott, J</creatorcontrib><creatorcontrib>WOLL, Matthew, G</creatorcontrib><creatorcontrib>ALAM, Rauful</creatorcontrib><creatorcontrib>PARKER, Erica, N</creatorcontrib><creatorcontrib>ZHANG, Xiaoyan</creatorcontrib><creatorcontrib>GILBERT, Bradley, B</creatorcontrib><creatorcontrib>NIEDERER, Kyle</creatorcontrib><creatorcontrib>ZHENG, Tianyi</creatorcontrib><creatorcontrib>TURPOFF, Anthony</creatorcontrib><creatorcontrib>JEON, Woohyung</creatorcontrib><creatorcontrib>LIU, Yao</creatorcontrib><creatorcontrib>ZHANG, Yan</creatorcontrib><creatorcontrib>RASTELLI, Ettore</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BEJCEK, Lauren</au><au>HOSSEYNI, Seyedmorteza</au><au>SYDORENKO, Nadiya</au><au>PILLAI, Meenu</au><au>HUARTE, Eduardo</au><au>ZHANG, Nanjing</au><au>GONG, Hua</au><au>Handoko</au><au>LI, Jing</au><au>BARRAZA, Scott, J</au><au>WOLL, Matthew, G</au><au>ALAM, Rauful</au><au>PARKER, Erica, N</au><au>ZHANG, Xiaoyan</au><au>GILBERT, Bradley, B</au><au>NIEDERER, Kyle</au><au>ZHENG, Tianyi</au><au>TURPOFF, Anthony</au><au>JEON, Woohyung</au><au>LIU, Yao</au><au>ZHANG, Yan</au><au>RASTELLI, Ettore</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INHIBITORS OF NLRP3</title><date>2024-07-03</date><risdate>2024</risdate><abstract>The present invention relates to novel compounds of Formulae I-XI: wherein each A, A′, Q, Q′, W, Rw, Y, and Z, and -- are as defined herein, which inhibit NOD-like receptor protein 3 (NLRP3) inflammasome activity. The invention further relates to the processes for their preparation, pharmaceutical compositions and medicaments containing them, and their use in the treatment of diseases and disorders mediated by NLRP3.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP4392414A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title INHIBITORS OF NLRP3
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T17%3A32%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BEJCEK,%20Lauren&rft.date=2024-07-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4392414A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true